Cushion for a respiratory mask assembly

Information

  • Patent Grant
  • 10850057
  • Patent Number
    10,850,057
  • Date Filed
    Friday, June 30, 2017
    7 years ago
  • Date Issued
    Tuesday, December 1, 2020
    3 years ago
  • Inventors
  • Original Assignees
  • Examiners
    • Douglas; Steven O
    Agents
    • Nixon & Vanderhye P.C.
Abstract
A respiratory mask assembly for delivering breathable gas to a patient includes a frame and a cushion. The cushion has a non-face contacting portion structured to be connected to the frame, a face-contacting portion structured to engage the patient's face, and an intermediate portion that interconnects the non-face contacting portion and the face-contacting portion. The intermediate portion includes a gusset portion that applies a first component of force to the patient's face through the face-contacting portion. A spring structure is coupled with the face-contacting portion of the cushion. The spring structure applies a second component of force to the patient's face through the face-contacting portion. The first and second components of force applied by the gusset portion and spring structure, respectively, determine a contact force of the cushion applied to the patient's face through the face-contacting portion. The intermediate portion may also include an elastic cuff portion. Further, in the case of an oral mask, the sealing section may include a portion that is designed to promote a better seal in the chin region of the mask.
Description
FIELD OF THE INVENTION

The present invention relates to a cushion for a respiratory mask assembly used for providing ventilatory support, e.g., for treatment of Sleep Disordered Breathing (SDB) with Non-invasive Positive Pressure Ventilation (NPPV).


BACKGROUND OF THE INVENTION

The use of NPPV for treatment of SDB such as Obstructive Sleep Apnea (OSA) was pioneered by Sullivan (see U.S. Pat. No. 4,944,310). Apparatus for the treatment of SDB involves a blower which delivers a supply of air at positive pressure to a patient interface via a conduit. The patient interface may take several forms, such as a nasal mask assembly and a nasal and mouth mask assembly. Patients typically wear a mask assembly while sleeping to receive the NPPV therapy.


Mask assemblies typically comprise a rigid shell or frame and a soft face-contacting cushion. The cushion spaces the frame away from the patient's face. The frame and cushion define a cavity which receives the nose or nose and mouth. The frame and cushion are held in position on the patient's face by a headgear assembly. The headgear assembly typically comprises an arrangement of straps which pass along both sides of the patient's face to the back or crown of the patient's head.


U.S. Pat. No. 5,243,971 (Sullivan and Bruderer) describes a nasal mask assembly for Continuous Positive Airway Pressure (CPAP) having a ballooning/molding seal that conforms with the patient's nose and facial contours. The mask assembly has a face-contacting portion mounted to a shell which is sized and shaped to overfit the nose region of the patient. The face-contacting portion is in the form of a distendable membrane which is molded from an elastic plastics material. The distendable membrane and the shell together define a chamber. Pressurized gas admitted to the chamber causes the membrane to distend outwardly from the patient's face. The contents of this patent are hereby incorporated by reference.


U.S. Pat. No. 6,112,746 (Kwok et al.) describes a nasal mask assembly and a mask cushion therefor. The cushion comprises a substantially triangularly shaped frame from which extends a membrane. The frame has a scalloped edge by which the cushion is affixed to a mask body. The membrane has an aperture into which the patient's nose is received. The membrane is spaced away from the rim of the frame, and its outer surface is of substantially the same shape as the rim. The contents of this patent are hereby incorporated by reference.


In a traditional mask assembly including a cushion, a seal is formed between the cushion and the face of a patient as the result of a contact force which acts along a contact line of the cushion. The contact force typically is a function of tension in the headgear straps which acts through the frame of the mask assembly, the walls of the cushion and the seal-forming portion of the cushion. In a traditional mask assembly, the frame defines a cavity or volute adapted to receive at least a portion of the nose, with the cushion forming a perimeter of the cavity. Thus, in use, the portion of the patient's face within the cavity is exposed to air or breathable gas at positive pressure and hence receives a force as the result of that positive pressure.


PCT Patent Application AU01/00746, published as WO 01/97893 (Frater et al.), describes a mask assembly for delivering air to a patient that includes a suspension mechanism to allow relative movement between a face-contacting cushion and a mask shell. The suspension mechanism also provides a predetermined force to the cushion that is a function of mask pressure, displacement of the cushion, or both. The contents of this patent are hereby incorporated by reference.


U.S. Pat. No. 5,074,297 (Venegas) describes a respiratory mask assembly for use with intermittent positive pressure breathing treatment which is said to facilitate the formation and automatic adjustment of the seal between a patient's face and a facial unit of the respiratory mask. The respirator mask assembly comprises a facial unit, an expandable piston adjacent the facial unit and a rigid support structure attached to one end of the piston, and an attachment mechanism for securing the mask assembly to a patient. During the inspiration portion of the ventilation cycle a positive pressure is developed within the mask assembly, causing the piston to expand. Because the attachment mechanism and the support cooperate to resist significant expansion of the piston, a force is generated which presses the facial unit against the patient's face and maintains an air tight seal. When pressure within the mask unit decreases, the contact force on the facial unit is likewise decreased and the seal is eliminated.


A common problem with prior art mask assemblies, such as the mask assemblies taught by U.S. Pat. Nos. 5,074,297, 5,243,971 and 6,112,746 and PCT Patent Application AU01/00746, is patient comfort. Patients can develop sores and red marks on their faces after several hours use of a mask assembly. The nasal bridge area of the patient's face has been identified as being particularly sensitive.


Moreover, the face contacting portion may apply excessive pressure to the wearer's face resulting in discomfort and possibly skin irritation. This can occur when the face contacting portion is distorted beyond its normal range of elasticity to conform to certain facial contours, thus requiring the application of excessive forces to obtain a seal. In some cases, these excessive pressures and forces may cause the wearer's face to distort to conform with the face contacting portion, which increases wearer discomfort, facial soreness and ulceration.


Another common problem with prior art mask assemblies is buildup of CO2 in the mask cavity. Mask assemblies typically include a vent which allows the continuous washout of exhaled gasses from the cavity. One factor affecting the washout of exhaled gases is the dead space within the mask cavity.


Another common problem with these masks is a broken or ineffective seal, for example, the mask may become dislodged if the wearer rolls over when sleeping, thereby creating a drag force on the gas supply line which is transmitted to the mask and breaking the seal between the mask and wearer. If a mask is used for the administration of Continuous Positive Airway Pressure (CPAP) treatment for the condition obstructive sleep apnea, such a leak can result in a pressure supplied to the entrance of the wearer's airway that is below the therapeutic value. Thus, treatment becomes ineffective.


Another problem with mask assemblies which include a gusset section is visual size, both perceived and actual.


Another problem with existing full face masks occurs when wearers move their jaws during treatment, which often happens. As a result, air leaks are created below the mouth from the mid-region extending to the region at the sides or corners of the mouth.


It would be desirable to design a respiratory mask that can be securely sealed to a wearer's face without causing discomfort and minimize leak.


SUMMARY OF THE INVENTION

One aspect of the invention is directed towards a mask assembly having a cushion that provides more comfort to the patient.


Another aspect of the invention is directed towards a mask assembly having a cushion that controllably distributes facial contact pressure around the patient's face.


Another aspect of the invention is directed towards a mask assembly having a cushion that controllably distributes facial contact forces around a contact line on the patient's face.


Another aspect of the present invention provides a respiratory mask assembly for delivering breathable gas to a patient. The respiratory mask assembly according to one embodiment includes a frame and a cushion. The cushion has a non-face contacting portion structured to be connected to the frame, a face-contacting portion structured to engage the patient's face, and an intermediate portion that interconnects the non-face contacting portion and the face-contacting portion. The intermediate portion includes a gusset portion that applies a first component of force to the patient's face through the face-contacting portion. A spring structure is coupled with the face-contacting portion of the cushion. The spring structure applies a second component of force to the patient's face through the face-contacting portion. The first and second components of force applied by the gusset portion and spring structure, respectively, determine a contact force of the cushion applied to the patient's face through the face-contacting portion.


Another aspect of the invention is directed towards a mask assembly having a curvature which follows the line of the patient's face.


Another aspect of the invention is directed towards a mask assembly having a gusset portion which has minimal impingement of a patient's vision.


Another aspect of the invention is directed towards a mask assembly having a cushion with a gusset portion which has a low profile.


Another aspect of the invention is directed towards a mask assembly having a gusset portion which seals at a low pressure and which is comfortable at high pressures.


Another aspect of the invention is directed towards a mask assembly having a cushion with gusset portion which provides stop structures to regulate pressure distribution.


Another aspect of the invention is directed towards a mask assembly having a gusset portion providing additional footprint area and a spring section with a spring constant constructed so that the forces on the face from the cushion are a function of the additional footprint area, the mask pressure and the spring constant of the spring section.


Another aspect of the invention is to provide an elastic cuff to the cushion. The elastic cuff may have a modulus of elasticity which is greater than a modulus of elasticity of the remaining portions of the cushion, such that it may vary more easily deform or stretch in response to localized pressure and/or force changes between the mask and the wearer's face, thereby avoiding a compromise in the seal during movement of the patient. The elastic cuff may be formed in one piece with the cushion, along an intermediate portion of the cushion between the contacting and non-contacting portions of the cushion. The elastic cuff may also be formed separate from the cushion and assembled to the contacting and/or non-contacting portions of the cushion.


A further aspect of embodiments of the invention provides a full face mask with a cushion that forms a stable and reliable seal with a wearer's face.


An additional aspect of embodiments of the invention provides a full face mask that effectively seals the region directly below and/or to the sides of the lower lip.


A further aspect of embodiments of the invention provides a full face mask that offers effective sealing at relatively high pressures.


Another aspect of embodiments of the invention provides a full face mask that abuts the more stable bony regions of a wearer's face.


A further aspect of embodiments of the invention provides a full face mask that follows the natural contour of the face's bony structure below the mouth.


In one example, a full face respiratory mask comprises a frame including a breathable gas port and cushion. The frame defines an inner chamber that receives a wearer's nasal region and mouth. The cushion includes a flange connected to the frame, an inner rim defining an opening to the inner chamber of the frame, and a sealing portion disposed between the flange and the inner rim that contacts the wearer's face. The sealing portion includes a nasal seal section that spans a wearer's face above the wearer's nares, side seal sections extending from each side of the nasal seal section on both sides of the wearer's mouth, and a chin seal section that extends between the side sections. The chin seal section is upwardly curved in an arch to follow the chin's bony contour.


In another example, a cushion for use in a full face respiratory mask, comprises a flange for connection to a mask frame, an inner rim defining an opening for surrounding the wearer's nares and mouth, and a sealing portion disposed between the flange and the inner rim that contacts the wearer's face. The sealing portion includes a nasal seal section that spans a wearer's face above the wearer's nares, side seal sections extending from each side of the nasal seal section on both sides of the wearer's mouth, and a chin seal section that extends between the side sections, wherein the chin seal section is upwardly curved in an arch to follow the chin's bony contour.


Principles of these examples may be applied to any type of cushion for use on a respiratory mask, including but not limited to silicone elastomer, gel, foam or any combination thereof.


Principles of these examples may be applied to any type of respiratory mask, including CPAP systems or non-positive ventilation masks, such as respirators.


Other aspects, features and advantages of this invention will become apparent from the following detailed description when taken in conjunction with the accompanying drawings, which are a part of this disclosure and which illustrate, by way of example, principles of this invention.





BRIEF DESCRIPTION OF THE DRAWINGS

The accompanying drawings facilitate an understanding of the various embodiments of this invention. In such drawings:



FIG. 1 is a front perspective view illustrating a mask assembly having a cushion constructed in accordance with an embodiment of the invention;



FIG. 1B is a perspective view similar to FIG. 1;



FIG. 1C is a perspective view similar to FIG. 1, but taken from another angle;



FIG. 2 is a rear perspective view of the mask assembly shown in FIG. 1;



FIG. 2B is a perspective view similar to FIG. 2;



FIG. 3 is a rear view of the mask assembly shown in FIG. 1;



FIG. 3B is a perspective view similar to FIG. 3;



FIG. 4 is a side view of the mask assembly shown in FIG. 1;



FIG. 4B is a perspective view similar to FIG. 4;



FIG. 5 is a bottom view of the mask assembly shown in FIG. 1;



FIG. 5B is a top view of the mask assembly shown in FIG. 1;



FIG. 6 is a cross-sectional view of the cushion shown in FIG. 1;



FIG. 6B is a cross-sectional view of the cushion shown in FIG. 1 in accordance with an alternative embodiment of the invention;



FIG. 6C is a perspective view similar to FIG. 6;



FIG. 7 is a side view of the cushion shown in FIG. 1;



FIG. 7B is a perspective view similar to FIG. 7;



FIG. 8 is a perspective view of the cushion shown in FIG. 1;



FIG. 8B is a perspective view similar to FIG. 8;



FIG. 9 is a bottom view of the cushion shown in FIG. 1;



FIG. 9B is a perspective view similar to FIG. 9;



FIG. 10 is a front view of a gusset portion of the cushion shown in FIG. 1 superimposed on a patient's face;



FIG. 10B is a front view of a gusset portion of the cushion shown in FIG. 1 superimposed on a patient's face, the contact line of the membrane on the patient's face shown in dashed lines;



FIG. 11 is a front view of a gusset portion of the cushion shown in FIG. 1;



FIG. 11B is a perspective view similar to FIG. 11;



FIG. 12 is a front view illustrating different embodiments of a gusset portion of the cushion shown in FIG. 1;



FIG. 12B is a front view similar to FIG. 12 illustrating different embodiments of a gusset portion of the cushion shown in FIG. 1;



FIG. 12C is a front view similar to FIG. 12 illustrating a different embodiment of a gusset portion of the cushion shown in FIG. 1;



FIGS. 13A-13C are cross-sectional views illustrating different embodiments of a spring structure within a gusset portion of the cushion shown in FIG. 1;



FIG. 14 is a partial top view illustrating an embodiment of the cushion shown in FIG. 1;



FIG. 15 is a cross-section taken along line 15-15 of FIG. 14;



FIG. 16 is a cross-section taken along line 16-16 of FIG. 14;



FIG. 17 is a cross-section taken along line 17-17 of FIG. 14;



FIG. 18 is a cross-section taken along line 18-18 of FIG. 14;



FIG. 19 is a cross-section taken along line 19-19 of FIG. 14;



FIG. 20 is a cross-section taken along line 20-20 of FIG. 14;



FIG. 21 is a cross-section taken along line 21-21 of FIG. 14;



FIG. 22 is a cross-section taken along line 22-22 of FIG. 14;



FIG. 23 is a partial top view illustrating an embodiment of the cushion shown in FIG. 1;



FIG. 24 is a cross-section taken along line 24-24 of FIG. 23;



FIG. 25 is a cross-section taken along line 25-25 of FIG. 23;



FIG. 26 is a cross-section taken along line 26-26 of FIG. 23;



FIG. 27 is a cross-section taken along line 27-27 of FIG. 23;



FIG. 28 is a cross-section taken along line 28-28 of FIG. 23;



FIG. 29 is a cross-section taken along line 29-29 of FIG. 23;



FIG. 30 is a cross-section taken along line 30-30 of FIG. 23;



FIG. 31 is a cross-section taken along line 31-31 of FIG. 23;



FIG. 32 is a cross-section taken along line 32-32 of FIG. 23;



FIG. 33 is a cross-section taken along line 33-33 of FIG. 23;



FIG. 34 is a front perspective view of an embodiment of the cushion shown in FIG. 1;



FIG. 35 is a rear perspective view of the cushion shown in FIG. 34;



FIG. 36 is a top view of the cushion shown in FIG. 34;



FIG. 37 is a side view of the cushion shown in FIG. 34;



FIG. 38 is a cross-section taken along line 38-38 of FIG. 36;



FIG. 39 is a cross-section taken along line 39-39 of FIG. 36;



FIG. 40 is a cross-section taken along line 40-40 of FIG. 36;



FIG. 41 is a cross-section taken along line 41-41 of FIG. 40;



FIG. 42 is an enlarged cross-sectional view of FIG. 38;



FIG. 43 is a graph that illustrates the relation between mask pressure and contact force on the patient's face for a mask with at least a gusset portion wherein the gusset portion is held at a fixed extension;



FIG. 44 is a graph that illustrates the effect a spring structure has on the total force applied to the patient's face at a constant mask pressure;



FIG. 45 is a cross-sectional view of another embodiment of the invention including an elastic nasal cuff.



FIG. 46 is a force versus displacement graph for ResMed's Activa™ mask;



FIG. 47 is a force versus displacement graph for a prior art mask;



FIG. 47A is a cross-sectional view of a mask according to the prior art;



FIG. 48 is a force versus displacement graph for an embodiment of the present invention;



FIG. 49 is a cross-sectional view of yet another nasal cuff embodiment of the present invention;



FIG. 50 is a front perspective view of a full face mask positioned on a wearer in accordance with a preferred embodiment of the invention;



FIG. 51 is a front perspective view of the mask frame and cushion in accordance with a preferred embodiment of the invention;



FIG. 52 is a rear perspective view of the cushion in accordance with a preferred embodiment of the invention;



FIG. 53 is a front view of the cushion of FIG. 52;



FIG. 54 is a rear view (from the wearer's side) of the cushion of FIG. 52;



FIG. 55 is a bottom view of the cushion of FIG. 52; and



FIG. 56 is a cross section side perspective view of the cushion taken along line 56-56 of FIG. 54.





DETAILED DESCRIPTION OF ILLUSTRATED EMBODIMENTS


FIGS. 1-5B show a respiratory mask assembly 10 that includes a frame 12 and a cushion 14 that may be permanently or removably connected to the frame 12. A forehead support 16 is movably mounted to an upper portion of the frame 12. A headgear assembly (not shown) can be removably attached to the frame 12 to maintain the frame 12 and cushion 14 in a desired adjusted position on the patient's face. For example, the headgear assembly may include a pair of upper and lower straps with the upper straps removably connected to clip structures 18 provided on the forehead support 16 and the lower straps removably connected to clip structures 20 provided on the frame 12. However, the headgear assembly and frame 12 may be removably attached to one another in any suitable manner.


In the illustrated embodiment, the mask assembly 10 is a nasal mask structured to deliver breathable gas to a patient's nose. However, the mask assembly 10 may be nasal and mouth mask or the mask assembly may be a full-face mask.


A swivel elbow assembly 22 is removably attached to a front portion of the frame 12. The elbow assembly 22 is structured to be connected to a conduit that is connected to a pressurized supply. The pressurized supply supplies pressurized breathable gas through the conduit and elbow assembly 22 and into the cushion 14 for breathing by the patient.


As shown in FIGS. 1-9B, the cushion 14 includes a non-face-contacting portion 24 (FIGS. 6 and 6C) structured to be connected to the frame 12, a face-contacting portion 26 structured to engage a patient's face, and an intermediate portion 28 that interconnects the non-face contacting portion 24 and the face-contacting portion 26. A seal-forming portion 68 (see FIG. 10B) of the cushion 14 is designed to seal on the patient's face. The cushion 14 achieves a seal by applying a contact force along the seal-forming portion 68 as will be described in further detail below. In one form, the seal-forming portion 68 is a strip with an area. For example, the strip 68 that contacts the patient's face could be that area between the dashed sets of lines in FIG. 10B. The contact force applied to sensitive regions on the patient's face can be minimized. Some portions of the patient's face require special attention to achieve a balance of comfort and seal.


In the illustrated embodiment, the non-face-contacting portion 24 of the cushion 14 is removably attached to the frame 12. For example, as shown in FIGS. 3, 3B, 6, 6C, and 15, the non-face-contacting portion 24 includes a shoulder 30 and a flange 32. A cushion clip 34 (see FIGS. 2, 2B, 3, and 3B) is detachably engaged with the frame 12 such that the shoulder 30 is positioned between the clip 34 and the frame 12 to attach the cushion 14 to the frame 12, e.g., see co-owned and co-pending U.S. patent application Ser. No. 10/235,846, filed on Sep. 6, 2002, incorporated herein by reference in its entirety. Further, the flange 32 is positioned to provide a seal. Alternatively, the non-face-contacting portion 24 of the cushion 14 may be removably attached to the frame 12 with straps, a friction or interference fit, and/or a tongue-and-groove arrangement, as is known in the art. However, the non-face-contacting portion 24 of the cushion 14 may be permanently attached to the frame 12 with glue and/or mechanical fastening means, for example.


As shown in FIGS. 6, 6C, and 14-33, a preferred face-contacting portion 26 of the cushion 14 includes a side wall 36, a rim 38 extending away from the side wall 36, and a membrane 40 provided to substantially surround the rim 38, e.g., see U.S. Pat. No. 6,112,746 of Kwok et al. and U.S. Provisional Application No. 60/402,509, filed on Aug. 12, 2002, incorporated herein by reference in its entirety. The rim 38 and side wall 36 provide a support structure for the face-contacting portion 26 and the membrane 40 provides a sealing structure for the face-contacting portion 26.


The membrane 40 provides a large effective rolled over section (large radius) to allow some degree of movement or rotation of the mask assembly 10 relative to the patient's face, and prevents the membrane distal edge from irritating the patient's face. Further, the membrane 40 extends further than the edge of the rim 38 to prevent the rim 38 from being a source of irritation.


The rim 38 has a curved shape that curves inwardly into the nasal cavity of the cushion 14. While it is preferable that the membrane 40 be thinner than the rim 38, they could have the same thicknesses.


The inside surface of the membrane 40 is spaced from the outside surface of the rim 38 so as to form a compliant seal with the patient. By compliant seal, it is meant that the membrane 40 can accommodate small variations in the shape of a patient's facial/nasal features without undue force, and can account for small movement of the mask relative to the patient during use, while maintaining an effective seal. The spacing between the rim 38 and membrane 40 may vary in different regions of the patient's face.


As shown in FIGS. 2, 2B, and 10-11B, the face-contacting portion 26 of the cushion 14 preferably has a generally triangular shape and is structured to contact the nasal bridge, cheek, and lip regions of the patient. However, the face-contacting portion 26 may have any other suitable shape, e.g., a generally trapezoidal shape. In the illustrated embodiment, the cushion 14 includes a pair of cheek regions 44 to provide a seal in the crease between the cheeks and the sides of the nose, a lip region 46 to provide a seal below the nose and above the upper lip of the patient, and a nasal bridge region 42. The nasal bridge region 42 spans across the bridge and sloping sides of the bridge that intersect with the nasal crease formed between the cheeks and the sides of the nose. The transition between the lip region 46 and each cheek region 44 is where the cushion 14 begins to turn around the bottom of the nose towards the side of the nose. The transition between the nasal bridge region 42 and each cheek region 44 is where each cheek region 44 diverges upwardly towards the bridge of the nose. In other words, the nasal bridge region 42 starts where the cheek region 44 begins to angle upwardly. As shown in FIG. 40, the membrane 40 may include a preformed, contoured notch 48 in the nasal bridge region 42 to match generally the typical contours of the nasal bridge region of the patient.


The cushion 14, including the gusset portion 50, is curved to generally follow the curvature of the face. See FIGS. 4-5B and 7-9B. The advantages of the above structure include a reduced height profile, increased stability, better fit to the patient's face and a reduced visual impact. Other advantages include a reduced height at sides of the frame 12 and headgear clip section which might otherwise protrude from the mask frame, decreased weight and volume of silicone, decreased deadspace and stiffened gusset portion which holds its shape better.


In the illustrated embodiment, the membrane 40 is structured to contact an upper portion of the nasal bridge region of the patient. However, the membrane 40 may contact a lower portion of the nasal bridge region. For example, see U.S. Provisional Application No. 60/402,509, filed on Aug. 12, 2002, the contents of which are hereby incorporated by reference.


In the illustrated embodiment, the face-contacting portion 26 of the cushion 14 has a double-walled construction, e.g., one membrane 40 and one rim 38. However, the cushion 14 may have a single walled, triple walled or more walled construction. For example, a cushion with a combined membrane and rim could be provided, e.g., a single walled construction. Conversely, the support function of the rim could be accomplished with two or more support rims to support a single membrane, or two or more membranes could be provided over a single rim. In another alternative, the support function of the rim and the sealing function of the membrane could be split into two different members, which may be made of different materials, for example either being made of a foam. In another embodiment, a gel membrane may be used.


The intermediate portion 28 of the cushion 14 includes a gusset portion 50 that extends radially outwardly with respect to the non-face-contacting and face-contacting portions 24, 26. The gusset portion 50 allows the face-contacting portion 26 to move relative thereto. Furthermore, the gusset portion 50 has a larger footprint area than the face-contacting portion 26 (e.g., FIG. 10 shows the gusset portion 50 superimposed on a patient's face to illustrate the additional area provided by the gusset portion 50). The additional footprint area of the gusset portion 50 provides a contact force on the patient's face acting on the sealing strip 68 (FIG. 10B) through the membrane 40, which increases the sealing efficiency of the cushion 14, as will be further discussed.


As shown in FIGS. 6, 6C, and 15, the gusset portion 50 extends outwardly from the side wall 36 of the face-contacting portion 26 and curves back inwardly into the flange 32 of the non-face-contacting portion 24. Specifically, the gusset portion 50 includes a first side wall 52 extending outwardly from the side wall 36 of the face-contacting portion 26, a second side wall 54 extending outwardly from the flange 32 of the non-face-contacting portion 24, and an arcuate wall 56 that interconnects the first and second side walls 52, 54. The walls 52, 54, and 56 of the gusset portion 50 defines a space 57 therebetween. Thus, the gusset portion 50 is curved as viewed from above to follow the contour of the patient's face. As shown in FIG. 39, for example, the gusset portion has a radius of curvature in the range of 80-120 mm, preferably in the range of 95-105 mm.


The gusset portion 50 has an inner edge 58 and an outer edge 60. The inner edge 58 corresponds to an outer edge of the side wall 36 and the outer edge 60 corresponds to an apex of the arcuate wall 56 of the gusset portion 50. A perpendicular distance d is defined between the inner and outer edges 58, 60, as shown in FIGS. 6 and 10. The distance d may be varied to vary the pressure applied by the cushion 14 on the patient's face. The distance d2 is defined as shown in FIG. 10B to be the perpendicular distance between the outer edge 60 and a cushion contact line 61 on the face. The contact line 61 is the outer perimeter of the seal-forming portion 68, that is, the sealing strip of the cushion 14. The additional area between the contact line 61 and the outer edge 60 leads to an additional force on the membrane 40. The contact force on the patient's face is proportional to the pressure in the mask cavity and the footprint area of the gusset portion 50. Thus, the additional area of the gusset portion 50 may be varied, e.g., by varying the distance d, to vary the contact force applied to the patient's face.


An aspect of the invention is that the contact force is controllably distributed around the patient's face. The pressures and forces should be distributed while maintaining the cushion's seal. It is desirable to avoid localized pressure points along sensitive regions of the patient's face. For example, localized points of contact force should be avoided in the nasal bridge region to increase comfort to the patient.


Another aspect of the invention is that not only can the contact force be redistributed while maintaining the cushion seal, but also the patient's field of view can be optimized by reshaping the gusset area around the eyes. For example, as shown in FIG. 12C, the gusset portion 50 has cutaway portions 51 around the eyes to improve the patient's field of view.


Since the contact force applied to the patient's face is proportional to the footprint area of the gusset portion 50, it is possible to vary the force applied to different regions of the patient's face by varying the distance d in different regions of the gusset portion 50. For example, FIG. 12 shows a gusset portion 50 with two possible outer edges. A first outer edge 60, shown in a solid line, has an approximately constant distance d between the inner and outer edges 58, 60. In contrast, the second outer edge 260, shown in dashed lines, has a smaller distance d′ in the lip and nasal bridge regions in comparison to the cheek regions.


The gusset portion 50 can be provided in only selected regions of the face, and not others. It need not be provided along the entire perimeter of the cushion. For example, the gusset portion 50 could be provided along only the lip portion.


Thus, the gusset portion 50 with the outer edge 260 in dashed lines has a smaller contact force applied to the nasal bridge and lip regions of the patient's face than the gusset portion 50 with the outer edge 60 in a solid line. In this way, the contact force applied to the patient's face can be redistributed away from more sensitive areas of the patient's face, e.g., nasal bridge and lip region, and applied to less sensitive areas of the patient's face, e.g., cheek regions. Since the nasal bridge region of the patient's face is particularly sensitive, a gusset portion 50 with a reduced area in the nasal bridge region 42 should be more comfortable for the patient. However, the distance d can be tailored for any region of the gusset portion 50 to tailor the force applied to any region of the patient's face for maximum comfort. This can be done on a customized basis to get both an ideal force and a customized area around the cushion.



FIG. 12B shows another embodiment of a gusset portion 50 with two possible outer edges. A first outer edge 60, shown in a solid line, has a smaller distance between the outer edge 260 and an inner edge (not shown) in the lip and nasal bridge regions in comparison to the cheek regions. In contrast, the second outer edge 260, shown in dashed lines, has an approximately constant distance between the outer edge 60 and an inner edge.


The contact force applied to the contact line on the patient's face can be further tailored by adjusting a thickness of the arcuate wall 56 of the gusset portion, as shown in FIGS. 6, 6C, and 13A-C. The arcuate wall 56 acts as a spring structure to provide a component of the contact force on the patient's face through the membrane 40. The arcuate wall 56′ may have a uniform wall thickness or a thin cross-section as shown in FIG. 13A or the arcuate wall 56″ may have a thicker cross-section as shown in FIG. 13B, with the thinner arcuate wall 56′ providing a smaller component of force than the thicker arcuate wall 56″. The cross-section of the arcuate wall 56, 56′, 56″, 56′″ may vary around the perimeter of the gusset portion 50. For example, a gusset portion may have a thin walled arcuate wall in the patient's nasal bridge region, but a thicker walled arcuate wall in the patient's cheek region. Moreover, the arcuate wall may be varied in conjunction with the varying distance d, for example, by reducing the distance d but increasing the thickness of the arcuate wall.


Alternatively, the whole gusset portion 50 may be tapered, not just the arcuate wall.


The contact force applied to the contact line on the patient's face can be further tailored by providing internal stop structures 59 as shown in FIG. 13C at the gusset portion 50. The size, shape and geometry of these stop structures 59 can be arranged to vary stiffness in different sections of the gusset portion 50. For example, less stiff sections at nasal bridge region, stiffer sections at cheek region, to provide the required comfort and seal level.


In another form, the contact force applied to the contact line on the patient's face can be tailored by inserting a spring (e.g. a steel spring) in the gusset portion 50. The spring has a spring constant that is designed to allow adjustment of the component of force applied by the spring.


In these ways, the contact force on the contact line of the face is not solely a function of mask pressure, but can also, for example, be a function of the spring element within the gusset portion 50. This improves low pressure stability, reduces the sealing force at high pressure, and reduces the visual impact a large gusset portion might otherwise have.


In the illustrated embodiment, the gusset portion 50 as well as the non-face-contacting and face-contacting portions 24, 26 of the cushion 14 have a generally triangular shape. However, the gusset portion 50 and non-face-contacting and face-contacting portions 24, 26 of the cushion 14 may have any suitable shape, e.g., non-triangular shape. Further, the shape of the gusset portion 50 and non-face-contacting and face-contacting portions 24, 26 may be similar to one another or may be different from one another, e.g., the gusset portion has a triangular shape and the face-contacting and non-face-contacting portions have a generally trapezoidal shape.


The cushion 14 is constructed from a soft, flexible skin-compatible material such as silicone. The cushion 14 may be formed, for example, in a one shot injection molding process as is known in the art. However, the cushion 14 may be formed with any suitable material and may be formed by any suitable process. For example, while face contacting portion 26 of cushion 14 may have a softer grade material, the gusset portion may have a harder grade material to provide stiffness as a spring element. The non-face contacting portion 24 may have a stiffer grade material so a direct assembly to frame without a cushion clip may be possible.


The cushion 14 provides improved seal stability and comfort over prior art cushions. Specifically, the curvature of the cushion 14 improves stability of the mask assembly generally and the gusset portion improves stability of seal. Changing the distances d and d2 of the gusset portion in different regions of the patient's face improves patient comfort level.



FIGS. 14-33 show various cross-sections of the cushion 14. The various cross-sections illustrate the various distances between the rim and the membrane in different regions of the patient's face. Moreover, the various cross-sections illustrate the various structural configurations and distances d of the gusset portion 50 in different regions of the patient's face.



FIGS. 34-42 shows further structural details and various dimensions in one embodiment of the cushion 14. For example, the cushion 14 has a length in the range of 42-62 mm, preferably 52 mm, a height in the range of 90-110, preferably 100.5 mm, and a width in the range of 95-115 mm, preferably 103.2 mm. In an embodiment of the cushion 14, the dimensions illustrated in FIGS. 34-42 may vary ±62 or 100%.



FIG. 6B shows an alternative embodiment of the invention which includes a reinforcing ring 64 between the gusset portion 50 and face-contacting portion 26 of the cushion 14. In one form, the ring 64 is constructed from a thickened bead of silicone and is molded with the cushion 14. The ring 64 acts as a stiffening hoop reducing the tendency of the cushion 14 to expand at that point when under pressure. In another form, the ring 64 is made from polycarbonate and is overmolded or push-fit.


The face-contacting portion 26 of the cushion 14 has a surface which may be described by a function of at least one parameter, p, varying from 0 to 360 degrees representing angular position. With respect to the nose, the 0 degree position may be defined to be mid-nasal bridge and the nasal septum will occur at 180 degrees. FIGS. 15-22 and 24-33 depict a range of cross-sections cut at different angular positions, and hence different values of the parameter, p.


An advantage of the mask assembly 10 is that the contact force acting through the contact strip can be tailored to provide an acceptable seal at low mask pressures while not being too high at high mask pressures. For example, in a mask assembly having a gusset portion with no spring structure, the contact force might be too low at low mask pressures to provide a seal, forcing designers to increase the gusset area. This additional gusset area in turn would lead to an excessively high contact force at high mask pressures. The combination of a spring structure with a gusset portion means that at low mask pressures, the contact force may be provided by the spring structure, with the gusset portion making little additional contribution. At high mask pressures, the contact force provided by the gusset portion may be much greater than that provided by the spring structure. Thus, the mask assembly 10 provides a means to tailor the contact forces of a mask system over a range of pressures.


In another form of the invention, the extensibility of the headgear is changeable. For example, relatively inextensible headgear might be used for low mask pressures, while more extensible headgear may be used for high mask pressures, such as around 20 cm H2O. In one form, this is achieved by having duplicate straps within the headgear, one extensible, the other, relatively inextensible. At low pressures, both straps are used, the net effect being that the headgear is relatively inextensible. At high pressures, the inextensible strap is disengaged, with the result that the headgear is relatively extensible overall.



FIG. 43 illustrates the contact force on the patient's face for a mask with at least a gusset portion wherein the gusset portion is held at a fixed extension, e.g., expansion. The x-axis is the pressure inside the mask. The y-axis is the contact force on the patient's face. A zone of comfort and seal Z is defined by: (a) a range of typical operating pressures from 4 to 20 cm H2O; (b) a minimum contact force that is required to maintain a seal on a patient's face, the minimum contact force defined as an increasing function of the pressure inside the mask; and (c) a maximum comfortable contact force.


In accordance with an embodiment of the invention, the cushion is designed to include a gusset portion and spring structure such that the contact force applied by the cushion is maintained within the zone of comfort and seal Z.



FIG. 43 shows three lines for three hypothetical cushions with at least a gusset portion. In general, at a first approximation, contact force increases linearly with mask pressure as the result of the additional footprint area provided by the gusset portion.


A first line L1 represents a cushion with a gusset portion which has an additional footprint area of A1 and which does not include a spring structure. As illustrated, the contact force is below the minimum contact force required to make a seal for mask pressures below about 7 cm H2O. Thus, the cushion represented by line L1 falls outside the zone of comfort and seal Z. For higher pressures (e.g., mask pressures above about 7 cm H2O), the contact force from the gusset portion is sufficient to maintain a seal.


A second line L2 represents a cushion according to one embodiment of the invention with a gusset portion which has an additional footprint area of A1 and includes a spring structure. The effect of the spring structure is to provide an additional contact force at low mask pressures when the effect of the gusset portion is insufficient to provide the minimum sealing force. As a result, the cushion maintains a seal through the range of operating pressures. Moreover, the cushion represented by line L2 falls within the zone of comfort and seal Z throughout the range of operating pressures.


A third line L3 represents a cushion with a gusset portion which has an additional footprint area of 2×A1 and does not include a spring structure. The extra footprint area (twice that of the cushions represented by L1 and L2) results in the contact force of the cushion being sufficient to maintain a seal at a low mask pressure of 4 cm H2O. However, for mask pressures above about 10 cm H2O, the contact force exceeds the maximum comfortable contact force. Thus, the cushion represented by line L3 falls outside the zone of comfort and seal Z.


Thus, by combining a gusset portion with a spring structure in a cushion, a designer can tailor the contact force of the cushion such that it falls within the zone of comfort and seal Z throughout the working range of pressure. The same principles may be applied for different pressure ranges.


Further, the size of the zone Z may change (e.g., by changing the maximum comfortable contact force) depending on a particular region of the patient's face. For example, the maximum comfortable contact force may be reduced for a nasal bridge region of the face. As a result, the cushion can be tailored for that particular region such that it falls within the zone of comfort and seal Z throughout the range of operating pressures.



FIG. 44 illustrates the effect a spring structure has on the total force applied to the patient's face at a constant mask pressure. Fmask is the total force of the mask on a patient's face, as defined in WO 01/97893 (Frater et al.). The inclusion of the gusset portion on the mask allows the two sides of the cushion to travel relative to one another. When the extension or expansion of the gusset portion is 0 mm, the two sides of the cushion abut one another. When the extension of the gusset portion is 50 mm, the two sides of the cushion are 50 mm apart. The closer the two sides of the cushion are brought towards one another, the higher the value of Fmask.



FIG. 44 shows four lines that represent four different cushions. A first line L1 is for a cushion with a gusset portion with no spring structure and with an additional footprint area of A1. A second line L2 is for a cushion according to one embodiment of the present invention with a gusset portion, a spring structure, and an additional footprint area of 62% of A1. A third line L3 is for a cushion with a gusset portion without a spring structure and with an additional footprint area of 85% of A1. A fourth line L4 is for a cushion with a gusset portion without a spring structure and with an additional footprint area of 62% of A1.


As illustrated, the addition of a spring structure to a cushion having a gusset portion increases Fmask generally throughout the range of gusset extensions. As a result, a cushion may be constructed with a gusset portion having a smaller footprint area than would otherwise be required to provide sufficient Fmask to maintain a seal.


Further, the effect of the spring on Fmask can be determined for various mask pressures so that the cushion can be tailored for particular regions of the patient's face.


Elastic Cuff



FIGS. 45-49 show an alternative embodiment of the present invention which may be used in conjunction with earlier or later described embodiments. As shown in FIG. 45, a mask assembly 100 includes a mask frame 112, a cushion 114 and a strap 116, all of which can be assembled in a fashion which is similar to that described above in relation to other embodiments.


The frame includes an inlet 122 which is in communication with the source of pressurized air or breathable gas. Preferably, the inlet is connected to a swivel elbow which in turn is connected to an air delivery tube.


The cushion 114 includes a non-contacting portion 124 which is provided to the mask frame 112, as described above. The cushion 114 further includes a face contacting portion 126 and an intermediate portion 128 which is between the non-contacting portion and the face contacting portion 126. The face contacting portion 126 includes a face-contacting seal portion 168 including a membrane 140 and a rim 138, as described above.


The intermediate portion 128 may be provided with at least one cuff 170 that may be resiliently inflatable. The cuff 170 includes walls that can stretch as opposed to being simply flexible. As the straps 116 are tightened, membrane 140 and rim 138 are pushed onto the face. This action causes a force to be applied to the membrane 140, the rim 138 and the face-contacting portion 126, displacing the face contacting portion 126 in the direction of the non-contacting portion 124. The displacement of the face contacting portion 126 and its associated force causes the cuff 170 to balloon outwards. The force is dependent on the degree of strap tightening and the stiffness (force-displacement relationship) of the cuff 170. Initial inflation of the cuff 170 can be achieved via a valve 175. The valve 175 can be in communication with the same source which provides pressurized air to the breathing chamber 171 of the mask assembly 100, or the source can be a separate pressurized source independent of the source for providing pressurized breathable gas to the breathing chamber 171. The elastic cuff 170 can be formed in a single piece with the cushion 114. Alternatively, the elastic cuff 170 may be formed separately from the cushion 114, and later attached, e.g., using adhesives, mechanical fasteners, or the like, etc.


Current mask systems use inflatable cuffs that are relatively stiff being made from materials having a relatively high modulus of elasticity. By contrast the cuffs 170 of the present embodiment are designed to have a relatively low stiffness. This is achieved, e.g., by providing the cuffs 170 with walls that stretch under relatively low forces. Walls with this characteristic typically are made from a material with a relatively low modulus of elasticity. For example, the modulus of elasticity of the material of the elastic cuff material, as determined by bench testing, is in the range of 0.15 MPa to 0.6 MPa. The preferred value for the modulus of elasticity is in the range of 0.25 MPa to 0.45 MPa. In one example, the modulus of elasticity is about 0.35 MPa. In comparison, the gusset portion described above may have a modulus of elasticity of 0.40 MPa to 0.80 MPa, and preferably the modulus of elasticity is about 0.60 MPa. The modulus of elasticity for both the gusset and the elastic cuff 170 can be more or less than that stated above or modified to give the appropriate stretch characteristics in conjunction with the delivered mask pressure and headgear tension/strap displacement.


In the embodiments described above, for example in relation to FIG. 1, a mask system and cushion provided with a gusset produces a number of positive attributes, for example, the ability to maintain cushion seal with relative frame instability, less fine adjustment required of head gear straps to apply a cushion force towards the face to maintain a seal. A cushion provided with the elastic cuff 170 of FIG. 45 also exhibits similar results to the above embodiments. However, the elastic cuff forces are independent of the supply air from the flow generator.


Prior art masks use inflatable (verses elastic) cuffs or pneumatic seals and/or seal rings. These inflatable cuffs are typically made from PVC that has a relatively high modulus of elasticity causing them to be relatively stiff. Bench testing of this PVC material found that the modulus of elasticity was of the order of 5.2 MPa. Although they may include some flexibility, it is not resiliently expandable like the elastic cuff 170 shown in FIG. 45. Examples of inflatable cuffs with a relatively high modulus of elasticity include U.S. Pat. No. 4,971,051 to Toffolon and anesthesia masks available from King Systems.



FIGS. 46-48, respectively, are force-displacement (stiffness) graphs for 1) the embodiment shown above with a gusset (ResMed's Activa™ mask); 2) the Prior Art; and 3) the elastic cuff shown in FIG. 45. It should be noted that the horizontal axis in these graphs labeled ‘d’ represents the dimension shown as ‘d’ in FIG. 45 (described above) and FIG. 47A which shows a prior art mask frame 300 with straps 310 and an inflatable cuff 320. As shown in FIG. 46, the flattened region according to the Activa™ mask gives a mask system with greater tolerance to strap tension or mask instability while maintaining relatively constant force of cushion seal to face. See the line between points X-X in FIG. 46.


In contrast, the graph of FIG. 47 shows that the prior art inflatable cuff being made of a material with a relatively higher modulus of elasticity has a more linear force-displacement characteristic and is stiffer. Therefore slight changes in the mask or cushion relative to the face that result in small changes to the dimension will cause relatively large changes in the sealing force applied to the face. Therefore, this prior art mask system cannot maintain a good seal over increased displacement (due to instability). Strap tension is critical to maintain the tolerable level of comfort.


Therefore, one aspect of this embodiment is to produce an elastic cuff from a material with a relatively low modulus of elasticity, like that of a stretchy balloon. The elastic cuff material has the ability to stretch under standard strap tension experienced in this application.


When the mask is not fitted, the inflatable cuff is not necessarily under pressure. When fitted correctly, the cuff is compressed as the straps are tightened. Given the low modulus of elasticity of the elastic cuff material, the cuff is designed to stretch, billow, bloat and/or swell as the cuff elongates as shown in phantom in FIG. 45.


The force applied to the cushion seal could be fine tuned by modifying the stiffness of the cuff walls, e.g., increasing or decreasing the modulus of elasticity, or by pre-pressurizing the elastic cuff 170 via a valve that, in this example, would increase cushion seal forces when the cushion is displaced and/or fitted into position and the straps tensioned.


As shown in FIG. 48, the elastic cuff 170 is made from a material with a lower modulus of elasticity that produces a similar flattened line to that shown in FIG. 46. However, this graph is slightly angled as compared to FIG. 46, but it is flatter than that shown in FIG. 47. The ideal is to have the angle flat in the middle such as shown in FIGS. 46 and 48.


A stiffer cuff made from a material with a higher modulus of elasticity would produce a greater rate of fall as compared to that shown in FIG. 48. For prior art inflatable cuffs, the relatively very high stiffness results in a very large change in cushion seal force for very slight displacements that may lead to a loss of the seal of the face. Events that may lead to slight displacement include, for example, nocturnal movements that result in changes to strap tightness, human face fluid reduction, relaxation of the lower jaw, etc.


In a further embodiment, the elastic cuff 170 may be filled with any compressible or non-compressible fluid, or some combination thereof. The fluid could be, for example, air, flowable liquid, flowable or semi-flowable gel. In the case of air, the cuff walls in tension cause the air inside the cuff to compress and forces the cushion seal outwards towards the face; there is some compression of the air as it is a gas. In the case of liquid filled, all the force onto the cushion seal is acted on by the cuff wall tension alone without the influence of compressed gas also.


Change in behavior of the cushion is achieved by any of or combination of modulus of elasticity, geometry/shape of the elastic cuff, material choice (for example the modulus of elasticity), and the initial mass of fluid (before fitting).


The initial mass of fluid may be adjusted by a valve either manually or automatically (incorporating external-internal control relative to cuff pressure and/or treatment CPAP pressure). In FIG. 45, it can be seen that the elastic cuff is separate from the cushion assembly, i.e. that portion of the cushion which seals against the face. It therefore provides minimal possible displacement, and only describes a flexible pneumatic seal, not elastic or resilient.


In FIG. 45, the expandable/contractible elastic cuff 170 is incorporated into the cushion seal.


In another embodiment, the elastic cuff may be pressurized with a manual pump 180 to fine tune the initial mass of fluid in the elastic cuff 170. See, for example, FIG. 49.


Another embodiment may incorporate automatic cuff mass of fluid change that can synchronize to delivered treatment pressure and/or react to leak or discomfort sensing.


Any elastic material that can be formed into a chamber or the elastic cuff 170 may be used. The use of a latex balloon is one material that may be used. Also, low durometer and/or low modulus of elasticity characteristic silicone rubbers may also be used, or a combination thereof. The cuff may have rigid or semi-rigid detail to provide structural integrity.


The cuff 170 need not surround the entire perimeter. For example, it may be excluded around the nasal bridge to modify received cushion seal forces. The elastic cuff 170 as disclosed herein may also be incorporated or used in conjunction with prior art mask systems, to create a new and improved product. For example, Respironics makes a “Profile Lite” gel cushion that could incorporate the elastic cuff 170 either integrated or otherwise attached between the frame and sealing interface. The elastic cuff may be filled with a compressible or non-compressible fluid such as air or gel, or any combination thereof.


In another example, the elastic cuff 170 may be combined with aspects of U.S. Pat. No. 4,971,051 to Toffolon. The elastic cuff could be incorporated as part of the cushion assembly to provide a force action in the cushion seal and also independent movement/displacement of the cushion seal relative to the mask frame.


While a nasal mask has been described in the preferred embodiments, the principles of the invention can be applied to full-face masks or mouth masks. Furthermore, the principles of the invention can be applied to nasal masks having a very small sealing region sealing near the nares.


“Boomerang” Seal



FIGS. 50-56 illustrate another embodiment of the invention which may be usable with earlier embodiments. FIG. 50 is a perspective view of the full face respiratory mask 10 secured to a wearer's head. The mask 10 includes a frame 12 that supports a cushion 14. The mask 10 is secured over the wearer's nasal area and mouth by head gear that includes fastening straps 16 that may be adjusted around the wearer's head.


The frame 12 is preferably saddle shaped, generally triangular or trapezoidal to fit over the wearer's nose, or at least over the wearer's nares, and extends downwardly on each side of the mouth to the chin. The frame 12 has a port 18 for connection to a breathable gas supply 20 through a swivel elbow assembly 22. The gas supply 20 may be a pressurized gas supply that supplies breathable gas to an inner chamber in the mask 10 that receives the wearer's nose and mouth.


The frame 12 also preferably includes a vent opening 24 through which expired gas is exhausted. Fasteners 26 are provided to secure the straps 16 of the head gear and allow selective adjustment of the head gear. In this case, the fasteners 26 are slots formed in the frame 12 through which the straps 16 are fed. Of course, any suitable fastener can be used. If desired, a forehead support may also be used, which would extend from the frame upward toward the forehead.


The frame 12 is shown alone with the cushion 14 in FIG. 51. As can be appreciated by those of ordinary skill in the art of respiratory masks, the cushion 14 may be secured to a flange 28 on the frame 12 by a variety of methods. The cushion 14 may be formed integral with the flange 28, it may be adhered to the flange 28, or it may be removably clipped thereto. Other methods of attachment could also be used including straps, friction or interference fit, or tongue and groove.


In FIG. 52, the cushion 14 is removed from the frame 12 and flipped over with respect to the view in FIG. 51 to show the face contacting portions of the cushion 14. The cushion 14 includes a flange 30 that connects to the mask 12, an inner rim 32 that defines an opening 34 to the inner chamber of the frame 12, and a sealing portion 36 disposed between the flange 30 and the inner rim 32.


Preferably, the cushion 14 is formed of a soft, flexible skin compatible material such as silicone. One suitable material is SILASTIC™, a silicone elastomer manufactured by Dow Corning. It may be molded, by a one shot injection process as known in the art, for example. Different portions of the cushion 14 may be made with different thicknesses, or even of different materials to affect stiffness and resiliency for example. It is also contemplated that the cushion 14 may be made in whole or in part of foam or gel materials. The cushion 14 may be made based on a combination of the above processes and materials.


The inner rim 32 and sealing portion 36 are best seen in FIG. 56, which shows that the sealing portion 36 has a gently curved shape that provides a lip that extends beyond the inner rim 32. Preferably, the sealing portion 36 is formed to be more flexible or thinner than the inner rim 32 to conform more easily to the wearer's facial contours. The sealing portion 36 offers a compliant seal, which can accommodate small variations in the shape of the wearer's face and can account for small movements of the mask relative to the wearer while maintaining an effective seal. Depending upon the securing force supplied to the mask 10, the cushion 14 may deform to a point where it butts against the rim 32. The flange 30 has a rigidity sufficient to withstand usual securing pressures in use of the full-face cushion 14 and tends to retain its shape and resist deformation. It thus also acts as a supporting structure.


The embodiment shown herein has a single rim 32 and a single sealing portion 36 thus forming a double walled construction. It is also possible to have a single, triple or multiple walled construction. Further, the rim 32 and the sealing portion 36 could be made of different materials.


If desired, the sealing portion 36 can include a gusset portion that is a gently curved enlarged portion that follows the curvature of the face.


The sealing portion 36 is designed to contact the wearer's face and form a seal therewith so that the gas supplied to the inner chamber of the frame 12 does not leak outside the mask 10. The sealing portion 36 includes a nasal section 38 that spans the nasal area, which extends above the wearer's nares across the bridge of the nose and is generally an inverted V-shape as seen in FIGS. 52-54. On each side of the nasal section 38, side sections 40 extend downwardly to the outside of both sides of the wearer's mouth, continuing the generally inverted V-shape. A chin section 42 extends between the side sections 40 and is described in greater detail below.


The profile of the cushion 14 when viewed from above or below has an concave central portion at the nasal end and the chin end and a convex portion at the cheek portions to fit a wearer's face as seen in FIG. 55. That is, in the plane perpendicular to a wearer's face, the cushion 14 is curved to follow the contours of the human face, including the protruding nose and chin. This is known in the art of respiratory masks.


Referring to FIGS. 53 and 54, the chin section 42 of the cushion 14 assumes a shape when viewed from the front and the rear that is not conventional in respiratory masks. As discussed above, in conventional masks, the chin section of a cushion is straight or U-shaped in the plane generally parallel to the wearer's face. The conventional idea is to make the chin section conform closely around the mouth. However, in this embodiment of the invention, the chin section 42 is shaped to closely conform to the chin's bony contour instead. The bone descriptor for this region is between the mental protuberance and lower teeth on the jaw, and it forms an outwardly extending bone line that is curved downward, much like the shape of a frown. The cushion 14 therefore includes the chin region 42 that is shaped like a boomerang or an inverted U and is designed to rest between the lower lip and the mental protuberance. As seen in FIG. 54, the shape of the seal may be described as W-shaped. Any portion of the inverted U or W shape may be adjustable to refine the fit on the wearer. For example, a malleable wire could be formed in the sealing portion to provide such adjustability, by bending the wire to conform the sealing portion to the wearer's facial contours. This upwardly curved design or arch is seen in FIGS. 51-54. The section rear view may have an arched shape while the front and/or side views could still maintain the current shape of the full face mask.


This shape allows the side sections 40 to extend farther downward toward the lower jaw. If desired, the cushion 14 can be sized to extend to the lower jaw to provide more stable support. By this, the cushion 14 rests on the bony regions of the face that are less likely to change shape and compromise the seal than the softer, fatty regions like the lower lip and cheek.


During treatment, as pressure is applied to the wearer, the lips, which are flexible, are forced slightly open. The lower lip thus moves outwardly and slightly downwards. As the lower lip moves as described, an intimate contact with the arch shaped cushion 14 is created, improving the sealing even further, and/or reducing leak through the mouth, if desired.


The cushion 14 and mask 10 have been described with reference to CPAP or assisted respiration treatment, however it is to be understood that the invention generally is applicable to any application where gas and/or atomized liquid is to be supplied to the entrance of the airways. Such applications include nebulisers, gas masks and anesthetic machines. In addition, the mask can be for use with an oral only mouth mask where the mask covers the mouth only. Also, the cushion could extend down beyond the chin to further stabilize the cushion.


It can thus be appreciated that the aspects of the present invention have been fully and effectively accomplished. The foregoing specific embodiments have been provided to illustrate the structural and functional principles of the present invention, and are not intended to be limiting. To the contrary, the present invention is intended to encompass all modifications, alterations and substitutions within the spirit and scope of the detailed description.

Claims
  • 1. A respiratory mask assembly, comprising: a frame; anda cushion provided to the frame, the cushion including:a non-face contacting portion provided to the frame;a face-contacting portion adapted to engage a patient's face;a gusset portion between the non-face contacting portion and the face-contacting portion, the gusset portion including a fold configured to expand and contract to allow relative movement between the non-face contacting portion and the face-contacting portion; anda stop structure configured and arranged to travel relative to the non-face contacting portion during expansion and contraction of the fold in use,wherein the stop structure is configured and arranged to abut an opposing surface of the cushion to provide a stop to contraction of the fold when a range of contraction provided by the fold has reached a predetermined limit in use.
  • 2. The respiratory mask assembly according to claim 1, wherein the cushion forms at least a portion of a breathing chamber, and the stop structure is arranged along an internal surface of the cushion within the breathing chamber.
  • 3. The respiratory mask assembly according to claim 1, wherein the stop structure is provided to a side wall of the fold.
  • 4. The respiratory mask assembly according to claim 1, wherein the stop structure comprises a thickened portion of a side wall of the cushion.
  • 5. The respiratory mask assembly according to claim 1, wherein the face-contacting portion, the gusset portion, and the stop structure comprise silicone.
  • 6. The respiratory mask assembly according to claim 1, wherein the non-face contacting portion, the face-contacting portion, the gusset portion, and the stop structure comprise silicone.
  • 7. The respiratory mask assembly according to claim 1, wherein the stop structure is arranged to vary a stiffness of a side wall of the cushion.
  • 8. The respiratory mask assembly according to claim 1, wherein the stop structure is arranged to vary stiffness in different regions of the cushion.
  • 9. The respiratory mask assembly according to claim 1, wherein the stop structure is arranged to vary stiffness in different regions of the gusset portion.
  • 10. The respiratory mask assembly according to claim 1, wherein the gusset portion extends outwardly from the non-face contacting portion.
  • 11. The respiratory mask assembly according to claim 1, wherein the gusset portion interconnects the non-face contacting portion and the face-contacting portion.
  • 12. The respiratory mask assembly according to claim 1, wherein the non-face contacting portion is removably connectable to the frame.
  • 13. The respiratory mask assembly according to claim 1, wherein the non-face contacting portion is removably connectable to the frame with a cushion clip.
  • 14. The respiratory mask assembly according to claim 1, wherein the cushion comprises an integrally formed, one piece construction.
  • 15. The respiratory mask assembly according to claim 1, further comprising a forehead support provided to an upper portion of the frame.
  • 16. The respiratory mask assembly according to claim 15, further comprising headgear including upper straps removably connected to the forehead support and lower straps removably connected to clip structures provided to the frame.
  • 17. The respiratory mask assembly according to claim 1, further comprising a swivel elbow assembly provided to a front portion of the frame.
  • 18. The respiratory mask assembly according to claim 1, wherein the gusset portion extends around a portion of a perimeter of the cushion.
  • 19. The respiratory mask assembly according to claim 1, further comprising a clip structure detachably engageable with the frame such that the non-face contacting portion is positioned between the clip structure and the frame to attach the cushion to the frame.
  • 20. The respiratory mask assembly according to claim 1, wherein the respiratory mask assembly is a nasal and mouth mask assembly.
  • 21. The respiratory mask assembly according to claim 1, wherein the respiratory mask assembly is a nasal mask assembly.
  • 22. The respiratory mask assembly according to claim 1, wherein the cushion forms at least a portion of a breathing chamber, and the stop structure is arranged along an internal surface of the cushion within the breathing chamber,wherein the stop structure comprises a thickened portion of a side wall of the cushion,wherein the face-contacting portion, the gusset portion, and the stop structure comprise silicone,wherein the gusset portion extends outwardly from the non-face contacting portion, andwherein the gusset portion extends around a portion of a perimeter of the cushion.
  • 23. The respiratory mask assembly according to claim 22, further comprising a forehead support provided to an upper portion of the frame, further comprising headgear including upper straps removably connected to the forehead support and lower straps removably connected to clip structures provided to the frame,further comprising a swivel elbow assembly provided to a front portion of the frame, andfurther comprising a clip structure detachably engageable with the frame such that the non-face contacting portion is positioned between the clip structure and the frame to attach the cushion to the frame.
  • 24. A respiratory mask assembly, comprising: a frame; anda cushion provided to the frame, the cushion including:a non-face contacting portion provided to the frame;a face-contacting portion adapted to engage a patient's face;a gusset portion between the non-face contacting portion and the face-contacting portion, the gusset portion including a fold configured to expand and contract to allow relative movement between the non-face contacting portion and the face-contacting portion; anda stop structure configured and arranged to travel relative to the non-face contacting portion during expansion and contraction of the fold in use,wherein the stop structure is configured and arranged to abut an opposing surface of the cushion to provide a stop to contraction of the fold when a range of contraction provided by the fold has reached a predetermined limit in use,wherein the cushion forms at least a portion of a breathing chamber, and the stop structure is arranged along an internal surface of the cushion within the breathing chamber,wherein the stop structure comprises a thickened portion of a side wall of the cushion,wherein the face-contacting portion, the gusset portion, and the stop structure comprise silicone, andwherein the fold extends outwardly from the non-face contacting portion.
  • 25. The respiratory mask assembly according to claim 24, wherein the stop structure is arranged to vary stiffness in different regions of the gusset portion.
  • 26. The respiratory mask assembly according to claim 24, wherein the cushion comprises an integrally formed, one piece construction.
  • 27. The respiratory mask assembly according to claim 24, wherein the gusset portion extends around a portion of a perimeter of the cushion.
  • 28. The respiratory mask assembly according to claim 24, further comprising a clip structure detachably engageable with the frame such that the non-face contacting portion is positioned between the clip structure and the frame to attach the cushion to the frame.
  • 29. The respiratory mask assembly according to claim 1, wherein the face-contacting portion includes a side wall and sealing membrane extending from the side wall, the sealing membrane providing a rolled over section adapted to form a seal with the patient's face.
  • 30. The respiratory mask assembly according to claim 29, wherein the gusset portion includes a first side wall extending from the side wall of the face-contacting portion, a second side wall extending from the non-face contacting portion, and an arcuate wall that interconnects the first and second side walls.
  • 31. The respiratory mask assembly according to claim 1, wherein the fold extends radially outwardly beyond the non-face contacting portion.
CROSS REFERENCE TO PRIORITY APPLICATIONS

This application is a continuation of U.S. patent application Ser. No. 14/251,000, filed Apr. 11, 2014, now allowed, which is a continuation of U.S. patent application Ser. No. 13/067,211, filed May 17, 2011, now U.S. Pat. No. 8,733,358, which is a continuation of U.S. patent application Ser. No. 12/382,517, filed Mar. 18, 2009, now U.S. Pat. No. 7,958,893, which is a divisional of U.S. patent application Ser. No. 10/655,622, filed Sep. 5, 2003, now U.S. Pat. No. 7,523,754, which claims the benefit of U.S. Provisional Application No. 60/424,686, filed Nov. 8, 2002, U.S. Provisional Application No. 60/483,622, filed Jul. 1, 2003, and is a Continuation-In-Part of U.S. Non-Provisional application Ser. No. 10/235,846, filed Sep. 6, 2002, now U.S. Pat. No. 6,823,869, which in turn claims priority to U.S. Provisional Application No. 60/317,486, filed Sep. 7, 2001 and U.S. Provisional Application No. 60/342,854, filed Dec. 28, 2001. Each of the above identified applications is incorporated herein by reference in its entirety.

US Referenced Citations (373)
Number Name Date Kind
443191 Illing Dec 1890 A
781516 Guthrie, Jr. Jan 1905 A
1081745 Johnston Dec 1913 A
1125542 Humphries Jan 1915 A
1192186 Greene Jul 1916 A
1229050 Donald Jun 1917 A
1282527 Bidonde Oct 1918 A
1362766 McGargill Dec 1920 A
1445010 Feinberg Feb 1923 A
1610793 Kaufman Dec 1926 A
1873160 Sturtevant Aug 1932 A
2353643 Bulbulian Jul 1944 A
2415846 Randall Feb 1947 A
2433565 Korman Dec 1947 A
2625155 Engelder Jan 1953 A
2706983 Matheson Apr 1955 A
2931356 Schwarz Apr 1960 A
3013556 Galleher Dec 1961 A
3330273 Bennett Jul 1967 A
3670726 Mahon et al. Mar 1972 A
3682171 Dali et al. Aug 1972 A
3739774 Gregory Jun 1973 A
3754552 King Aug 1973 A
3861385 Carden Jan 1975 A
3902486 Guichard Sep 1975 A
3905361 Hewson et al. Sep 1975 A
3938614 Ahs Feb 1976 A
3972321 Proctor Aug 1976 A
4006744 Steer Feb 1977 A
4142527 Garcia Mar 1979 A
4153051 Shippert May 1979 A
4156426 Gold May 1979 A
4248218 Fischer Feb 1981 A
4263908 Mizerak Apr 1981 A
4264743 Maruyama et al. Apr 1981 A
4267845 Robertson, Jr. et al. May 1981 A
4273124 Zimmerman Jun 1981 A
4312359 Olson Jan 1982 A
4367735 Dali Jan 1983 A
4367816 Wilkes Jan 1983 A
4406283 Bir Sep 1983 A
4414973 Matheson et al. Nov 1983 A
4422456 Teip Dec 1983 A
4449526 Elam May 1984 A
4455675 Bose et al. Jun 1984 A
4493614 Chu et al. Jan 1985 A
4548200 Wapner Oct 1985 A
4549542 Chein Nov 1985 A
4572323 Randall Feb 1986 A
4587967 Chu et al. May 1986 A
4601465 Roy Jul 1986 A
4617637 Chu et al. Nov 1986 A
4630604 Montesi Dec 1986 A
4641647 Behan Feb 1987 A
4660555 Payton Apr 1987 A
4671271 Bishop et al. Jun 1987 A
4676241 Webb Jun 1987 A
4699139 Marshall et al. Oct 1987 A
4706664 Snook et al. Nov 1987 A
4711636 Bierman Dec 1987 A
4713844 Westgate Dec 1987 A
D293613 Wingler Jan 1988 S
4753233 Grimes Jun 1988 A
4767411 Edmunds Aug 1988 A
4774946 Ackerman et al. Nov 1988 A
4782832 Trimble et al. Nov 1988 A
4790829 Bowden et al. Dec 1988 A
4802857 Laughlin Feb 1989 A
4803981 Vickery Feb 1989 A
4811730 Milano Mar 1989 A
4830138 Palmaer et al. May 1989 A
4838878 Kalt et al. Jun 1989 A
4899740 Napolitano Feb 1990 A
4907584 McGinnis Mar 1990 A
4915105 Lee Apr 1990 A
4919128 Kopala et al. Apr 1990 A
4919654 Kalt Apr 1990 A
4944310 Sullivan Jul 1990 A
4945907 Tayebi Aug 1990 A
4960121 Nelson et al. Oct 1990 A
4966590 Kalt Oct 1990 A
4969880 Zamierowski Nov 1990 A
4971051 Toffolon Nov 1990 A
4976698 Stokley Dec 1990 A
4989599 Carter Feb 1991 A
4996983 Amrhein Mar 1991 A
5000173 Zalkin et al. Mar 1991 A
5003633 Itoh Apr 1991 A
5005571 Dietz Apr 1991 A
5020163 Aileo et al. Jun 1991 A
5022900 Bar-Yona et al. Jun 1991 A
5023955 Murphy, II et al. Jun 1991 A
5025805 Nutter Jun 1991 A
5038772 Kolbe et al. Aug 1991 A
5042478 Kopala et al. Aug 1991 A
5046491 Derrick Sep 1991 A
5074297 Venegas Dec 1991 A
5113857 Dickerman et al. May 1992 A
5117818 Palfy Jun 1992 A
5121745 Israel Jun 1992 A
5127397 Kohnke Jul 1992 A
5137017 Salter Aug 1992 A
5138722 Urella et al. Aug 1992 A
D333015 Farmer et al. Feb 1993 S
5188101 Tumolo Feb 1993 A
5207665 Davis et al. May 1993 A
5220699 Farris Jun 1993 A
5243709 Sheehan et al. Sep 1993 A
5243971 Sullivan et al. Sep 1993 A
5245995 Sullivan et al. Sep 1993 A
5261893 Zamierowski Nov 1993 A
5263939 Wortrich Nov 1993 A
5265592 Beaussant Nov 1993 A
5265595 Rudolph Nov 1993 A
5267557 Her-Mou Dec 1993 A
5269296 Landis Dec 1993 A
5271391 Graves Dec 1993 A
5304146 Johnson et al. Apr 1994 A
5299599 Farmer et al. May 1994 A
5335656 Bowe et al. Aug 1994 A
5349949 Schegerin Sep 1994 A
5355878 Griffiths et al. Oct 1994 A
5355893 Mick et al. Oct 1994 A
5364367 Banks et al. Nov 1994 A
5372130 Stem et al. Dec 1994 A
5372388 Gargiulo Dec 1994 A
5372389 Tam et al. Dec 1994 A
5372390 Conway et al. Dec 1994 A
5372391 Bast et al. Dec 1994 A
5375593 Press Dec 1994 A
5385141 Granatiero Jan 1995 A
5394568 Brostrom et al. Mar 1995 A
5396885 Nelson Mar 1995 A
5398676 Press et al. Mar 1995 A
5400776 Bartholomew Mar 1995 A
5419318 Tayebi May 1995 A
5425359 Liou Jun 1995 A
5429683 Le Mitouard Jul 1995 A
5437267 Weinstein et al. Aug 1995 A
5441046 Starr et al. Aug 1995 A
5462528 Roewer Oct 1995 A
5477852 Landis et al. Dec 1995 A
5526806 Sansoni Jan 1996 A
5488948 Dubruille et al. Feb 1996 A
5509409 Weatherholt Apr 1996 A
5513634 Jackson May 1996 A
5513635 Bedi May 1996 A
5533506 Wood Jul 1996 A
5538000 Rudolph Jul 1996 A
5538001 Bridges Jul 1996 A
5560354 Berthon-Jones et al. Oct 1996 A
5570684 Behr Nov 1996 A
5592938 Scarberry et al. Jan 1997 A
5623923 Bertheau et al. Apr 1997 A
5647357 Barnett et al. Jul 1997 A
5653228 Byrd Aug 1997 A
5655527 Scarberry et al. Aug 1997 A
5662101 Ogden et al. Sep 1997 A
5682881 Winthrop et al. Nov 1997 A
5704345 Berthon-Jones Jan 1998 A
5707342 Tanaka Jan 1998 A
5724965 Handke et al. Mar 1998 A
5735272 Dillon et al. Apr 1998 A
5740799 Nielson Apr 1998 A
5752511 Simmons et al. May 1998 A
5794619 Edeiman et al. Aug 1998 A
5807341 Heim Sep 1998 A
5842469 Rapp Dec 1998 A
5906203 Klockseth et al. May 1999 A
5918598 Belfer et al. Jul 1999 A
5921239 McCall et al. Jul 1999 A
5954049 Foley et al. Sep 1999 A
5975079 Hellings et al. Nov 1999 A
6019101 Cotner et al. Jan 2000 A
6026811 Settle Feb 2000 A
6044844 Kwok et al. Apr 2000 A
6082360 Rudolph et al. Jul 2000 A
6086118 McNaughton et al. Jul 2000 A
6095996 Steer et al. Aug 2000 A
6098205 Schwartz et al. Aug 2000 A
6109263 Feuchtgruber Aug 2000 A
6112746 Kwok Sep 2000 A
6119693 Kwok et al. Sep 2000 A
6119694 Correa et al. Sep 2000 A
6123071 Berthon-Jones et al. Sep 2000 A
6123082 Berthon-Jones Sep 2000 A
6139787 Harrison Oct 2000 A
6152137 Schwartz et al. Nov 2000 A
6193914 Harrison Feb 2001 B1
6196223 Belfer et al. Mar 2001 B1
6211263 Cinelli et al. Apr 2001 B1
6231548 Bassett May 2001 B1
6241930 Harrison Jun 2001 B1
6258066 Urich Jul 2001 B1
6295366 Haller et al. Sep 2001 B1
6328038 Kessler et al. Dec 2001 B1
6341606 Bordewick et al. Jan 2002 B1
6347631 Hansen et al. Feb 2002 B1
6357441 Kwok et al. Mar 2002 B1
6358279 Tahi et al. Mar 2002 B1
6374826 Gunaratnam et al. Apr 2002 B1
6412487 Gunaratnam et al. Jul 2002 B1
6412488 Barnett et al. Jul 2002 B1
6412593 Jones Jul 2002 B1
6419660 Russo Jul 2002 B1
6422238 Lithgow Jul 2002 B1
6423036 Van Huizen Jul 2002 B1
6431172 Bordewick Aug 2002 B1
6434796 Speirs Aug 2002 B1
6439234 Curti et al. Aug 2002 B1
6448303 Paul Sep 2002 B1
6467482 Boussignac Oct 2002 B1
6467483 Kopacko et al. Oct 2002 B1
6470887 Martinez Oct 2002 B1
6478026 Wood Nov 2002 B1
6482178 Andrews et al. Nov 2002 B1
6491034 Gunaratnam et al. Dec 2002 B1
6513526 Kwok et al. Feb 2003 B2
6530373 Patron et al. Mar 2003 B1
6532961 Kwok et al. Mar 2003 B1
6536435 Fecteau et al. Mar 2003 B1
6561188 Ellis May 2003 B1
6561190 Kwok et al. May 2003 B1
6561192 Palmer May 2003 B2
6561193 Noble May 2003 B1
6571798 Thornton Jun 2003 B1
6579267 Lynch et al. Jun 2003 B2
6581601 Ziaee Jun 2003 B2
6581602 Kwok et al. Jun 2003 B2
6584975 Taylor Jul 2003 B1
6595214 Hecker et al. Jul 2003 B1
6595215 Wood Jul 2003 B2
6607516 Cinelli et al. Aug 2003 B2
6627289 Dilnik et al. Sep 2003 B1
6631718 Lovell Oct 2003 B1
6634358 Kwok et al. Oct 2003 B2
6637434 Noble Oct 2003 B2
6644315 Ziaee Nov 2003 B2
6655385 Curti et al. Dec 2003 B1
6663600 Bierman et al. Dec 2003 B2
6669712 Cardoso Dec 2003 B1
D485905 Moore et al. Jan 2004 S
6679257 Robertson et al. Jan 2004 B1
6679265 Strickland et al. Jan 2004 B2
6701927 Kwok et al. Mar 2004 B2
6710099 Cinelli et al. Mar 2004 B2
6766800 Chu et al. Jul 2004 B2
6766817 da Silva Jul 2004 B2
6776162 Wood Aug 2004 B2
6776163 Dougill et al. Aug 2004 B2
6789543 Cannon Sep 2004 B2
6805117 Ho et al. Oct 2004 B1
6807967 Wood Oct 2004 B2
6817362 Gelinas et al. Nov 2004 B2
6820617 Robertson et al. Nov 2004 B2
6823865 Drew et al. Nov 2004 B2
6823869 Raje et al. Nov 2004 B2
6834650 Fini Dec 2004 B1
6860270 Sniadach Mar 2005 B2
6895965 Scarberry et al. May 2005 B2
6907882 Ging et al. Jun 2005 B2
6918404 Dias da Silva Jul 2005 B2
6926004 Schumacher Aug 2005 B2
6938620 Payne, Jr. Sep 2005 B2
6968844 Liland Nov 2005 B2
6972003 Bierman et al. Dec 2005 B2
6986352 Frater et al. Jan 2006 B2
6997177 Wood Feb 2006 B2
7011090 Drew et al. Mar 2006 B2
7018362 Bierman et al. Mar 2006 B2
7052127 Harrison May 2006 B2
7066586 da Silva Jun 2006 B2
7076282 Munro et al. Jul 2006 B2
7080645 Genger et al. Jul 2006 B2
7101359 Kline et al. Sep 2006 B2
7107989 Frater et al. Sep 2006 B2
7146976 McKown Dec 2006 B2
7152599 Thomas Dec 2006 B2
7152601 Barakat et al. Dec 2006 B2
7178525 Matula, Jr. et al. Feb 2007 B2
7191781 Wood Mar 2007 B2
7207328 Altemus Apr 2007 B1
7210481 Lovell et al. May 2007 B1
7237551 Ho et al. Jul 2007 B2
7243723 Surjaatmadja Jul 2007 B2
D550836 Chandran et al. Sep 2007 S
D552733 Criscuolo et al. Oct 2007 S
7285255 Kadlec et al. Oct 2007 B2
7302950 Berthon-Jones et al. Dec 2007 B2
7318437 Gunaratnam et al. Jan 2008 B2
7523754 Lithgow et al. Apr 2009 B2
7658189 Davidson Feb 2010 B2
7958893 Lithgow et al. Jun 2011 B2
20010020474 Hecker et al. Sep 2001 A1
20020005198 Kwok et al. Jan 2002 A1
20020029780 Frater et al. Mar 2002 A1
20020046755 DeVoss Apr 2002 A1
20020053347 Ziaee May 2002 A1
20020066452 Kessler et al. Jun 2002 A1
20020069872 Gradon et al. Jun 2002 A1
20020096178 Ziaee Jul 2002 A1
20020124849 Billette De Villemeur Sep 2002 A1
20020143296 Russo Oct 2002 A1
20020157673 Kessler et al. Oct 2002 A1
20020174868 Kwok et al. Nov 2002 A1
20020185134 Bishop Dec 2002 A1
20030000526 Goebel Jan 2003 A1
20030019495 Palkon et al. Jan 2003 A1
20030075180 Raje et al. Apr 2003 A1
20030079749 Strickland et al. May 2003 A1
20030089373 Gradon et al. May 2003 A1
20030111080 Olsen et al. Jun 2003 A1
20030154980 Berthon-Jones et al. Aug 2003 A1
20030168063 Gambone et al. Sep 2003 A1
20030196656 Moore et al. Oct 2003 A1
20030196658 Ging et al. Oct 2003 A1
20040025882 Madaus et al. Feb 2004 A1
20040025885 Payne, Jr. Feb 2004 A1
20040045551 Eaton et al. Mar 2004 A1
20040065328 Amarasinghe et al. Apr 2004 A1
20040106891 Langan et al. Jun 2004 A1
20040111104 Schein et al. Jun 2004 A1
20040112384 Lithgow et al. Jun 2004 A1
20040118406 Lithgow et al. Jun 2004 A1
20040127856 Johnson Jul 2004 A1
20040211428 Jones Oct 2004 A1
20040226564 Persson Nov 2004 A1
20040226566 Gunaratnam et al. Nov 2004 A1
20050011523 Aylsworth et al. Jan 2005 A1
20050028822 Sleeper et al. Feb 2005 A1
20050033247 Thompson Feb 2005 A1
20050039757 Wood Feb 2005 A1
20050051171 Booth Mar 2005 A1
20050051176 Riggins Mar 2005 A1
20050056286 Huddart et al. Mar 2005 A1
20050061326 Payne, Jr. Mar 2005 A1
20050101933 Marrs et al. May 2005 A1
20050150495 Rittner et al. Jul 2005 A1
20050155604 Ging et al. Jul 2005 A1
20050211252 Lang et al. Sep 2005 A1
20050241644 Gunaratnam et al. Nov 2005 A1
20050284481 Meyer Dec 2005 A1
20060060200 Ho et al. Mar 2006 A1
20060081250 Bordewick et al. Apr 2006 A1
20060095008 Lampropoulos et al. May 2006 A1
20060095009 Lampropoulos et al. May 2006 A1
20060118117 Berthon-Jones Jun 2006 A1
20060124131 Chandran et al. Jun 2006 A1
20060137690 Gunaratnam et al. Jun 2006 A1
20060174887 Chandran et al. Aug 2006 A1
20060207597 Wright Sep 2006 A1
20060237017 Davidson et al. Oct 2006 A1
20060283461 Lubke et al. Dec 2006 A1
20070023044 Kwok et al. Feb 2007 A1
20070125387 Zollinger et al. Jun 2007 A1
20070144525 Davidson et al. Jun 2007 A1
20070186930 Davidson et al. Aug 2007 A1
20070272249 Chandran et al. Nov 2007 A1
20070282272 Bannon et al. Dec 2007 A1
20080004573 Kaufmann et al. Jan 2008 A1
20080006277 Worboys et al. Jan 2008 A1
20080047560 Veliss et al. Feb 2008 A1
20080060649 Veliss et al. Mar 2008 A1
20080065022 Kyvik et al. Mar 2008 A1
20080110469 Weinberg May 2008 A1
20080200880 Kyvik et al. Aug 2008 A1
20080257354 Davidson et al. Oct 2008 A1
20090044808 Guney et al. Feb 2009 A1
20090178679 Lithgow et al. Jul 2009 A1
20100000534 Kooij et al. Jan 2010 A1
20100018534 Veliss et al. Jan 2010 A1
20110220114 Lithgow et al. Sep 2011 A1
20140202464 Lithgow et al. Jul 2014 A1
Foreign Referenced Citations (93)
Number Date Country
199651130 Oct 1996 AU
2005100738 Nov 2005 AU
185017 May 1907 DE
30 11 900 Oct 1980 DE
146 688 Feb 1981 DE
37 19 009 Dec 1988 DE
39 27 038 Feb 1991 DE
29723101 UI Jul 1998 DE
197 03 526 Aug 1998 DE
199 44 242 Mar 2001 DE
100 02 571 Jul 2001 DE
102 13 905 Oct 2002 DE
10 2004 055 433 Nov 2004 DE
0 288 937 Nov 1988 EP
0 427 474 May 1991 EP
0 466 960 Jan 1992 EP
303090 Apr 1992 EP
0 658 356 Jun 1995 EP
0 776 679 Jun 1997 EP
1099452 May 2001 EP
1 116 492 Jul 2001 EP
1 258 266 Nov 2002 EP
1 481 702 Dec 2004 EP
2 720 280 Dec 1995 FR
532214 Jan 1941 GB
2 176 404 Dec 1986 GB
2 368 533 May 2002 GB
2 385 533 Aug 2003 GB
H03-007173 Jan 1991 JP
2000-515784 Nov 2000 JP
2003-175106 Jun 2003 JP
2003-535657 Dec 2003 JP
WO 1982003548 Oct 1982 WO
WO 1987001950 Apr 1987 WO
WO 1992020392 Nov 1992 WO
WO 1992020395 Nov 1992 WO
WO 1996028207 Sep 1996 WO
WO 1998004310 Feb 1998 WO
9812965 Apr 1998 WO
WO 1998023305 Jun 1998 WO
WO 1999016327 Apr 1999 WO
WO 1999025410 May 1999 WO
WO 1999043375 Sep 1999 WO
9961088 Dec 1999 WO
WO 2000020072 Apr 2000 WO
WO 2000038772 Jul 2000 WO
WO 2000050121 Aug 2000 WO
WO 2000069521 Nov 2000 WO
0078384 Dec 2000 WO
WO 2000072905 Dec 2000 WO
WO 2000074758 Dec 2000 WO
WO 2000076568 Dec 2000 WO
0162326 Aug 2001 WO
0197893 Dec 2001 WO
WO 2001095965 Dec 2001 WO
WO 2001097892 Dec 2001 WO
WO 2002038221 May 2002 WO
WO 2002045784 Jun 2002 WO
WO 2003090827 Nov 2003 WO
WO 2003105921 Dec 2003 WO
WO 2004022146 Mar 2004 WO
WO 2004041342 May 2004 WO
WO 2004073778 Sep 2004 WO
WO 2004078230 Sep 2004 WO
WO 2005053781 Jun 2005 WO
WO 2005063328 Jul 2005 WO
WO 2005086943 Sep 2005 WO
WO 2005099801 Oct 2005 WO
WO 2005110220 Nov 2005 WO
WO 2005118040 Dec 2005 WO
PCTAU2006000031 Jan 2006 WO
PCTAU2006000417 Mar 2006 WO
PCTAU2006000770 Jun 2006 WO
WO 2006069415 Jul 2006 WO
WO 2006074513 Jul 2006 WO
WO 2006074516 Jul 2006 WO
WO 2006099658 Sep 2006 WO
WO 2006130903 Dec 2006 WO
WO 2007009182 Jan 2007 WO
WO 2007041751 Apr 2007 WO
WO 2007041786 Apr 2007 WO
WO 2007048174 May 2007 WO
WO 2007053878 May 2007 WO
PCTAU2007001936 Dec 2007 WO
WO 2007143772 Dec 2007 WO
WO 2007145534 Dec 2007 WO
WO 2008011682 Jan 2008 WO
WO 2008011683 Jan 2008 WO
WO 2008040050 Apr 2008 WO
WO 2008070929 Jun 2008 WO
WO 2009108994 Sep 2009 WO
WO 2009109004 Sep 2009 WO
WO 2010028425 Mar 2010 WO
Non-Patent Literature Citations (94)
Entry
Decision of Rejection issued in Japanese Application No. 2010-195597 dated Apr. 28, 2014, with English translation thereof.
Decision to Reject the Amendments issued in corresponding Japanese Appln. No. 2010-195597 dated Apr. 28, 2014, with English translation thereof.
Summons to Attend Oral Proceedings issued in corresponding European Appln. No. 03793493.2 dated May 6, 2014.
Office Action issued in corresponding Japanese Application No. 2010-195597 dated Jul. 27, 2015, with English translation thereof.
Extended European Search Report dated Jun. 3, 2015 issued in European Application No. 15160073.1.
“Ear Loop Face Mask”.
Adam J. Singer MD et al. “The Cyanoacrylate Topical Skin Adhesives,” American Journal of Emergency Medicine, vol. 26, 2008, pp. 490-496.
Webster's Third New International Dictionary, 1993, Dictionary definition for adjustable, bendable, and mild steel.
ComfortLite™, Respironics, http://comfortlite.respironics.com.
ComfortLite™ 2, Respironics, http://comfortlite2.respironics.com.
“If You Hate CPAP! You Need CPAP Pro®,” www.cpappro.com.
Webster's New World Dictionary, Third College Edition 1988, definition for engaged and flexible.
European Search Report filed on Jul. 27, 2009 in EP Application No. 07784697.0.
European Search Report issued in EP 07845378.4, dated Dec. 1, 2009.
Examination Report filed in New Zealand Application 539836, dated Aug. 25, 2005.
Examiner's Report No. 3 dated Nov. 18, 2009 in New Zealand Application No. 2003275762.
Extended European Search Report dated Mar. 19, 2009 in European Application No. EP 08161249.
Extended European Search Report dated Sep. 3, 2009 in corresponding EP Application No. 09161984.1.
Extended European Search Report. Application No. EP 08154854, dated Nov. 27, 2008.
Fisher and Paykel Col.—Product Family—http://www.fphcare.com/os a/products.asp/.
Hans Rudolph, Inc.—Mask Products—http://www.rudolphkc.com/products.php?category=MASKS.
International Preliminary Report on Patentability for PCT/AU2004/001832, dated Jul. 3, 2006.
International Search Report for PCT/AU2005/000803, dated Jun. 30, 2005.
International Search Report filed in PCT/AU2006/000770, dated Aug. 3, 2006.
International Search Report for PCT/AU2007/001052, dated Oct. 9, 2007.
International Search Report for PCT/AU2007/001051, dated Nov. 5, 2007.
International Search Report for PCT/AU2004/001832, dated Mar. 24, 2005.
International Search Report for PCT/AU2007/001936, dated Mar. 4, 2008.
Joel W. Beam, “Tissue Adhesives for Simple Traumatic Lacerations,” Journal of Athletic Training, 2008, vol. 43, No. 2, pp. 222-224.
Merriam-Webster Online Dictionary definition of moveable from the 14th century.
Office Action dated Dec. 22, 2009 in European Appln. No. 04802133.1.
ResMed Co.—Mask Products—http://resmed.com/portal/site/ResMedUS/index.jsp? . . . .
Respironics Co.—Mask Family—http://masksfamily.respironics.com/.
Snapp Nasal Interface, Tiara Medical Systems, Inc.—http://www.tiaramed.com/asp_shops/shopdisplayproducts.asp?id=109&cat=SNAPP%2A+Nasal+Interface.
Subbu Venkatraman et al., “Review Skin Adhesives and Skin Adhesion 1. Transdermal Drug Delivery Systems,” Biomaterials, vol. 19, 1998, pp. 1119-1136.
Supplementary European Search Report dated Sep. 8, 2009 in European Appln. No. 04802133.1.
Supplementary European Search Report dated Dec. 18, 2009 in European Application No. 03810331.3.
Supplementary Search Report issued in European Appln. 05746824.1, dated Dec. 17, 2009.
Unsolicited email from Elson Silva, PhD, dated Mar. 28, 2008, “Requesting IDS of US 6,766,817 for patents on fluids moving on porosity by Unsaturated Hydraulic Flow,” (email provided in both HTML and plain text format).
International Search Report PCT/AU2003/001163, dated Nov. 4, 2003.
International Search Report PCT/AU2003/001471, dated Feb. 12, 2004.
International Search Report PCT/AU2009/000240, dated May 21, 2009.
International Search Report PCT/AU2009/000262, dated Jun. 9, 2009.
International Search Report PCT/AU2009/001144, dated Dec. 18, 2009.
U.S. Appl. No. 10/385,701, filed Aug. 2003, Berthon-Jones et al.
U.S. Appl. No. 10/533,928, filed Jul. 2005, Berthon-Jones.
U.S. Appl. No. 10/584,711, filed Dec. 2004, Davidson.
U.S. Appl. No. 10/781,929, filed Jan. 2008, Gunaratnam et al.
U.S. Appl. No. 10/871,929, filed Feb. 2004, Surjaatmadja.
U.S. Appl. No. 11/080,446, filed Jul. 2005, Ging et al.
U.S. Appl. No. 11/447,295, filed Jun. 2006, Lubke et al.
U.S. Appl. No. 11/474,415, filed Jun. 2006, Davidson et al.
U.S. Appl. No. 11/491,016, filed Feb. 2007, Kwok et al.
U.S. Appl. No. 11/597,909, filed Jul. 2007, Worboys.
U.S. Appl. No. 11/703,082, filed Feb. 2007, Davidson.
U.S. Appl. No. 11/878,932, filed Jul. 2007, Veliss et al.
U.S. Appl. No. 11/878,933, Jul. 2007, Veliss et al.
U.S. Appl. No. 12/081,696, filed Apr. 2008, Davidson et al.
U.S. Appl. No. 12/085,191, filed May 2008, Kwok et al.
U.S. Appl. No. 12/219,852, filed Jul. 2008, Guney et al.
U.S. Appl. No. 12/309,696, filed Jan. 2009, Kwok et al.
U.S. Appl. No. 12/448,250, filed Jun. 2009, Veliss et al.
U.S. Appl. No. 12/461,448, filed Aug. 2009, Berthon-Jones.
U.S. Appl. No. 12/478,537, filed Jun. 2009, Kooij et al.
U.S. Appl. No. 12/656,466, filed Jan. 2010, Biener et al.
U.S. Appl. No. 12/700,878, filed Feb. 2010, Davidson et al.
U.S. Appl. No. 60/483,622, filed Jul. 2003, Kwok et al.
U.S. Appl. No. 60/533,214, filed Dec. 2003, Drew.
U.S. Appl. No. 60/634,802, filed Dec. 2004, Chandran.
U.S. Appl. No. 60/645,672, filed Jan. 2005, Chandran.
U.S. Appl. No. 60/795,615, filed Apr. 2006, Judson et al.
U.S. Appl. No. 60/833,841, filed Jul. 2006, Veliss.
U.S. Appl. No. 60/835,442, filed Aug. 2006, Selvarajan et al.
U.S. Appl. No. 60/852,649, filed Oct. 2006, Selvarajan et al.
U.S. Appl. No. 60/874,968, filed Dec. 2006, Kwok et al.
U.S. Appl. No. 60/907,856, filed Apr. 2007, Davidson et al.
U.S. Appl. No. 60/924,241, filed May 2007, Kwok et al.
U.S. Appl. No. 60/929,393, filed Jun. 2007, Kwok et al.
U.S. Appl. No. 60/935,179, filed Jul. 2007, Guney et al.
U.S. Appl. No. 60/935,336, filed Aug. 2007, Davidson et al.
U.S. Appl. No. 60/996,160, filed Nov. 2007, Guney et al.
U.S. Appl. No. 61/006,409, filed Jan. 2008, Guney et al.
U.S. Appl. No. 61/064,818, filed Mar. 2008, Guney et al.
U.S. Appl. No. 61/071,512, filed May 2008, Guney et al.
EP Supplementary Search Report issued in EP Appln. 03793493 (dated Dec. 2, 2009).
Office Action issued in European Appln. No. 03793493.2 (dated Mar. 18, 2011).
Office Action issued in Japanese Appln. No. 2009-140433 (dated Aug. 20, 2011).
Office Action issued in Chinese Appln. No. 201010000226.3 (dated Apr. 26, 2012).
Office Action issued in Japanese Appln. No. 2010-1955897 (dated Jun. 12, 2012).
Notice of Allowance issued in Japanese Appln. No. 2009-140433 (dated Sep. 4, 2012).
Office Action issued in Chinese Appln. No. 201010000226.3 (dated Jan. 14, 2013).
Office Action issued in Chinese Appln. No. 201010000226.3 (dated Jun. 3, 2013).
Office Action issued in European Appln. No. 03 793 493.2 (dated Jun. 7, 2013).
Final Office Action issued in Japanese Appln. No. 2010-195597 (dated Jun. 25, 2013).
Related Publications (1)
Number Date Country
20170296768 A1 Oct 2017 US
Provisional Applications (4)
Number Date Country
60483622 Jul 2003 US
60424686 Nov 2002 US
60342854 Dec 2001 US
60317486 Sep 2001 US
Divisions (1)
Number Date Country
Parent 10655622 Sep 2003 US
Child 12382517 US
Continuations (3)
Number Date Country
Parent 14251000 Apr 2014 US
Child 15638580 US
Parent 13067211 May 2011 US
Child 14251000 US
Parent 12382517 Mar 2009 US
Child 13067211 US
Continuation in Parts (1)
Number Date Country
Parent 10235846 Sep 2002 US
Child 10655622 US